Istvan Petak: Join me in DC and NYC to discuss precision oncology and AI
Istvan Petak shared a post on LinkedIn:
“Hello, East Coast Friends.
I’ll be in Washington, DC tomorrow, for the CancerX Summit, and then heading to New York for New York Venture Summit. If you’re in either city and want to chat about the future of precision oncology, artificial intelligence, Genomate Health, or grab a coffee, let’s make it happen. Looking forward to sparking new ideas. Drop me a message—I’d love to meet.”
Source: Istvan Petak/LinkedIn
Dr. Istvan Petak specialises in precision oncology and molecular pharmacology of targeted therapies. He is the founder and CEO of Genomate Health, Inc. Cambridge, MA, founder and board director of Oncompass Medicine, Budapest, HU, and adjunct professor at the Department of Pharmaceutical Sciences at the University of Illinois at Chicago (UIC).
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023